Synonyms: MMV533 | SAR121 | SAR441121
Compound class:
Synthetic organic
Comment: MMV688533 is the optimized lead from the acylguanidine series of antimalarial compounds [1]. The compound has progressed to clinical evaluation and was awarded MMV Project of the Year (2017).
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
References |
1. Murithi JM, Pascal C, Bath J, Boulenc X, Gnädig NF, Pasaje CFA, Rubiano K, Yeo T, Mok S, Klieber S et al.. (2021)
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance. Sci Transl Med, 13 (603). [PMID:34290058] |
2. Pascal C, Pellet A, Courtemanche G, Campbell S. (2019)
Ethynyl compounds, their preparation and their therapeutic use for the treatment of malaria. Patent number: WO2019008027A1. Assignee: Sanofi S.A.. Priority date: 04/07/2017. Publication date: 10/01/2019. |